Pitcairn’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $600K | Sell |
3,342
-642
| -16% | -$115K | 0.04% | 368 |
|
|
2025
Q1 | $674K | Buy |
+3,984
| New | +$674K | 0.04% | 349 |
|
|
2023
Q3 | – | Sell |
-3,042
| Closed | -$428K | – | 654 |
|
|
2023
Q2 | $428K | Sell |
3,042
-1,184
| -28% | -$166K | 0.04% | 410 |
|
|
2023
Q1 | $598K | Sell |
4,226
-521
| -11% | -$73.7K | 0.06% | 299 |
|
|
2022
Q4 | $743K | Sell |
4,747
-2,281
| -32% | -$357K | 0.07% | 234 |
|
|
2022
Q3 | $862K | Sell |
7,028
-1,533
| -18% | -$188K | 0.09% | 201 |
|
|
2022
Q2 | $1.14M | Buy |
8,561
+2,477
| +41% | +$329K | 0.12% | 156 |
|
|
2022
Q1 | $833K | Sell |
6,084
-3,367
| -36% | -$461K | 0.07% | 233 |
|
|
2021
Q4 | $1.64M | Buy |
9,451
+4,529
| +92% | +$784K | 0.11% | 137 |
|
|
2021
Q3 | $716K | Buy |
4,922
+2,962
| +151% | +$431K | 0.05% | 260 |
|
|
2021
Q2 | $258K | Buy |
1,960
+86
| +5% | +$11.3K | 0.02% | 535 |
|
|
2021
Q1 | $241K | Buy |
1,874
+187
| +11% | +$24K | 0.02% | 542 |
|
|
2020
Q4 | $201K | Buy |
+1,687
| New | +$201K | 0.02% | 556 |
|
|
2015
Q2 | – | Sell |
-5,793
| Closed | -$445K | – | 477 |
|
|
2015
Q1 | $445K | Sell |
5,793
-31
| -0.5% | -$2.38K | 0.05% | 284 |
|
|
2014
Q4 | $391K | Buy |
5,824
+136
| +2% | +$9.13K | 0.04% | 311 |
|
|
2014
Q3 | $345K | Sell |
5,688
-108
| -2% | -$6.55K | 0.04% | 345 |
|
|
2014
Q2 | $340K | Buy |
+5,796
| New | +$340K | 0.04% | 341 |
|
|
2013
Q3 | – | Sell |
-3,476
| Closed | -$211K | – | 451 |
|
|
2013
Q2 | $211K | Buy |
+3,476
| New | +$211K | 0.03% | 402 |
|